An invited commentary on this study, also published in JAMA Ophthalmology, challenges the idea that the increased risk of NAION among semaglutide users resulted directly from the medication
The website design reflects this focus on credibility
Pharmaceutical companies are also trying to capitalize on the success of this model by rolling out their own platforms: Pfizer rolled out its DTC platform, PfizerForAll, in 2024, and Novo Nordisk launched its direct-to-patient program, NovoCare Pharmacy, in 2025
This raises the possibility that GLP-1 agonists could be used in combination with existing treatments for OUD to improve outcomes for individuals trying to quit opioid use
The 5-session protocol was significantly more effective than the previous 3-session protocol (26.5% vs 10%, p = 0.0025)
And they just become preoccupied with food to the point where its distracting, de Souza said